Get in touch
Get in touch
Get in touch

Accelerate your immunotherapy breakthroughs

From millions of cells to your next therapeutic lead

Discover our services

about usWe enable rapid
immunotherapy development

Avigen is a Contract Research Organisation built on world-class research at the intersection of immunology, oncology, and engineering. We are transforming how immune cells are discovered and validated, combining microfluidics with biological insight to accelerate the development of breakthrough cellular immunotherapies.

Learn more about us

partnersWe are proudly supported by

servicesExplore our capabilities

scientist-at-work-researchingValidation
Immunotherapy validation
science-lab-freezerDiscovery
Immunotherapy discovery

technologyA new dimension in immunotherapy validation & selection

Our platform redefines how potent immune cells are identified—measuring cellular avidity to uncover what truly drives therapeutic success.

Chip veritcall
Physiological Relevance

Captures the full complexity of live immune–target cell interactions, delivering insights that better reflect in-vivo therapeutic behaviour.

High Throughput

Analyses tens of thousands of single-cell interactions per run—and scales to millions—enabling comprehensive profiling of diverse immune cell populations.

Gentle

Maintains cell viability and functionality for immediate downstream testing, seamlessly integrating into your existing R&D pipeline.

Highly Adaptable

Compatible with a wide range of adherent target cells and immune cell types, including TCR-T, CAR-T, NK, and beyond—across various solid tumour indications.

Explore our technology

Contact us to explore how we can help you develop your next therapy

explore what we doFeatured news

White City Incubator1
May 12, 2025

Avigen Joins the White City Incubator

Company News
Read more
New Project
April 1, 2025

Avigen Awarded £300K Grant to Accelerate Cell Therapy R&D Innovation

Press Release
Read more

get in touchWe are always ready to help and answer your questions

Interested in learning more, collaborating, or sharing ideas? We’re eager to partner with biotech and pharma focused on cellular immunotherapies for solid tumours.

Scale Space White City
58 Wood Lane, London W12 7RZ

Email

info@avigen.bio 

Social network
Linkedin-in

Contact us

Please enable JavaScript in your browser to complete this form.